Potential Buy Entry Alert to Watch MYX

Time Frame : Daily/Weekly

Sector : Pharmaceuticals/Healthcare

Key Stats : $1.77 Billion Market Cap, VWAP 1.135, ASX Ranking 172, 4 Week Av Turnover $7,112,901, Current Turnover (Intraday as at time of alert) $4,171,487.

Company Overview : Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA.

Broker Consensus : BUY

MYX – Mayne Pharma Group Limited

MYX has been very good to us in the past and we are watching closely for another opportunity to jump on board for a run higher. The price has held up very well considering the pressure that the ASX has been under the lately so we are watching for evidence that buyers are taking control to build the entry setup.

Stock Code : MYX – Mayne Pharma Group Limited

Company Website : www.maynepharma.com

Current Price : 1.125

Status : On watch for buy entry setup